Financing
Wondering how you could obtain the best level of care and comfort for your loved ones or yourself?
We share with you the below information to help you assess and maximise your financial resources.
Cancer Drug List
The Cancer Drug List (CDL), developed by the Ministry of Health (MOH), is a list of outpatient cancer drugs and clinical indications that are claimable under MediShield Life (MSHL), MediSave (MSV) and Integrated Shield Plans (IP).
It shows the outpatient cancer treatments that are claimable and the corresponding MSHL claim limits and MSV withdrawal limits. On the other hand, IP have claim limits set by the private insurance providers of up to five times up the MSHL claim limit, depending on the policy. IP with riders offer additional coverage beyond the CDL. Some of the IP with riders may cover non-CDL treatment, among other benefits.
How will the CDL affect me?
Each outpatient cancer drug treatment on the CDL has its own MSHL claim limits and MSV withdrawal limits. That means, MSHL and MSV claims are dependent on both the drug and the indication for which it is being used for. Claim limits may change from time to time and the corresponding limits will be applied based on the date that the treatment is administered.
The CDL, corresponding subsidy levels and claim limits will be updated every few months to keep up with medical advancements and the latest clinical evidence.
The list of outpatient cancer drug treatments that are claimable under MSHL and MSV, and their respective claim and withdrawal limits can be found here. Please consult your doctor to find out whether your outpatient cancer drug treatment is on the list.
Coverage
| Plan | Category | Coverage | Implementation Date | |
| Drug-indication on CDL | Drug-indication not on CDL | |||
| MediShield Life (MSHL) | Drug | Limit of $200 - $9,600/month | Not Applicable | 1 Sep 2022 |
| Services* | Limit of $3,600/year | 1 Apr 2023 | ||
| MediSave (MSV) | Drug | Limit of $600/month or $1,200/month, depending on the MSHL claim limit for the drug-indication | Not Applicable | 1 Sep 2022 |
| Services* | Limit of $600/year (including post-treatment scans) | |||
| IP (Private Insurer component) | Drug | Varies across insurers’ plans, and will be set as a multiple of MSHL limits | Riders will cover drug-indications beyond the CDL. Coverage varies across insurers’ plans | Upon policy purchase/ renewal from 1 Apr 2023 onwards |
| Services* | Varies across insurers' plans | |||
| Plan type: MediShield Life (MSHL) |
|---|
| Category: Drug |
| Coverage (Drug-indication on CDL): Limit of $200 - $9,600/month |
| Coverage (Drug-indication not on CDL): Not Applicable |
| Implementation Date: 1 Sep 2022 |
| Plan type: MediShield Life (MSHL) |
| Category: Services* |
| Coverage (Drug-indication on CDL):Limit of $3,600/year |
| Coverage (Drug-indication not on CDL): Limit of $3,600/year |
| Implementation Date: 1 Apr 2023 |
| Plan type: MediSave (MSV) |
| Category: Drug |
| Coverage (Drug-indication on CDL): Limit of $600/month or $1,200/month, depending on the MSHL claim limit for the drug-indication |
| Coverage (Drug-indication not on CDL): Not Applicable |
| Implementation Date: 1 Sep 2022 |
| Plan type: MediSave (MSV) |
| Category: Services* |
| Coverage (Drug-indication on CDL):Limit of $600/year (including post-treatment scans) |
| Coverage (Drug-indication not on CDL): Limit of $600/year (including post-treatment scans) |
| Implementation Date:1 Sep 2022 |
| Plan type:IP (Private Insurer component) |
| Category: Drug |
| Coverage (Drug-indication on CDL):Varies across insurers’ plans, and will be set as a multiple of MSHL limits |
| Coverage (Drug-indication not on CDL): Riders will cover drug-indications beyond the CDL. Coverage varies across insurers’ plans |
| Implementation Date: Upon policy purchase/ renewal from 1 Apr 2023 onwards |
| Plan type:IP (Private Insurer component) |
| Category: Services* |
| Coverage (Drug-indication on CDL):Varies across insurers' plans |
| Coverage (Drug-indication not on CDL):Varies across insurers' plans |
| Implementation Date: 1 Upon policy purchase/ renewal from 1 Apr 2023 onwards |
*Services refer to those that are part of the cancer drug treatment, including consultations, scans, lab investigations, chemotherapy preparation and administration, supportive care drugs and blood transfusions.
If you have an IP, your coverage will depend on the renewal date of your IP.
- If the renewal date of your IP is between 1 January 2023 and 31 March 2023, you will only be affected by the CDL claim limits upon the renewal of your policy in 2024. This means that you are still covered by your existing IP claim benefits until your current policy is renewed in 2024.
- If the renewal date of your IP is between 1 April 2023 to 30 September 2023, you will qualify for transitional support if you have undergone at least one inpatient or outpatient cancer drug treatment between 1 January 2023 to 31 March 2023 with a valid claim. Your current policy will also continue to provide coverage for your treatment until 30 September 2023.
This transitional support designed by MOH allows sufficient time for affected patients to adjust to the new changes so that treatment will not be disrupted. This support will end on 30 September 2023. - If the renewal date of your IP is between 1 October 2023 to 31 March 2024, you will continue to receive the current coverage until your policy renewal date.
Please check with your insurance provider on your coverage.
Frequently Asked Questions
With the introduction of the CDL, we have curated a list of the frequently asked questions to address some of your queries.
International Expatriate Insurance Plans
If you are an expatriate and have an insurance plan that covers you globally, please contact your insurer to obtain information on your medical coverage. With a Letter of Guarantee (LOG), direct billing arrangement can be made with the insurer.
The international insurance plans include the following:
- Cigna International
- BUPA International
- Aetna International
- International SOS
- Prestige International
- Vanbreda International
The following modes of payment are available at Parkway Cancer Centre:
- Cash
- Nets
- All major credit cards
- Cheque
Get in touch with us if you have any questions. Drop us at email at enquiry@pcc.sg.